Alexander Vang

640 total citations
21 papers, 415 citations indexed

About

Alexander Vang is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Alexander Vang has authored 21 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Alexander Vang's work include Pulmonary Hypertension Research and Treatments (14 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac Valve Diseases and Treatments (3 papers). Alexander Vang is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac Valve Diseases and Treatments (3 papers). Alexander Vang collaborates with scholars based in United States, Brazil and United Kingdom. Alexander Vang's co-authors include Gaurav Choudhary, Richard Clements, Havovi Chichger, Elizabeth O. Harrington, Danielle J. McCullough, Brian Casserly, Sharon Rounds, Alan Morrison, Qing Lü and Jin O‐Uchi and has published in prestigious journals such as Circulation, Scientific Reports and The FASEB Journal.

In The Last Decade

Alexander Vang

21 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Vang United States 12 188 182 133 50 43 21 415
Tomoko Nao Japan 14 98 0.5× 339 1.9× 260 2.0× 164 3.3× 47 1.1× 30 651
Christian Schach Germany 11 88 0.5× 232 1.3× 159 1.2× 117 2.3× 129 3.0× 27 504
Sara A. Murphy United States 7 49 0.3× 70 0.4× 166 1.2× 54 1.1× 53 1.2× 13 367
Arthur Leloup Belgium 15 54 0.3× 331 1.8× 144 1.1× 51 1.0× 177 4.1× 26 575
Han Feng China 13 64 0.3× 164 0.9× 266 2.0× 58 1.2× 128 3.0× 22 566
Shenglan Guo China 9 141 0.8× 84 0.5× 131 1.0× 30 0.6× 24 0.6× 15 342
H. J. L. Speirs Australia 10 69 0.4× 142 0.8× 410 3.1× 50 1.0× 39 0.9× 11 571
Kojiro Ichikawa Japan 11 43 0.2× 165 0.9× 62 0.5× 51 1.0× 51 1.2× 14 390
Péter Ferdinandy Hungary 11 22 0.1× 157 0.9× 219 1.6× 49 1.0× 65 1.5× 15 505
Nicholas P. Meermeier United States 8 256 1.4× 84 0.5× 580 4.4× 53 1.1× 34 0.8× 9 749

Countries citing papers authored by Alexander Vang

Since Specialization
Citations

This map shows the geographic impact of Alexander Vang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Vang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Vang more than expected).

Fields of papers citing papers by Alexander Vang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Vang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Vang. The network helps show where Alexander Vang may publish in the future.

Co-authorship network of co-authors of Alexander Vang

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Vang. A scholar is included among the top collaborators of Alexander Vang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Vang. Alexander Vang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vang, Alexander, et al.. (2025). Right Ventricular Stiffening and Anisotropy Alterations in Pulmonary Hypertension: Mechanisms and Relations to Right Heart Failure. Journal of the American Heart Association. 14(5). e037126–e037126. 2 indexed citations
2.
Zambrano, Byron A., et al.. (2025). Dissecting contributions of pulmonary arterial remodeling to right ventricular afterload in pulmonary hypertension. Bioengineering & Translational Medicine. 10(4). e70035–e70035. 1 indexed citations
3.
Zhang, Peng, Denielli da Silva Gonçalves Bós, Alexander Vang, et al.. (2024). Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension. Pulmonary Circulation. 14(2). e12358–e12358. 6 indexed citations
4.
Bós, Denielli da Silva Gonçalves, Alexander Vang, Owen P. Leary, et al.. (2023). Right Ventricular Architectural Remodeling and Functional Adaptation in Pulmonary Hypertension. Circulation Heart Failure. 16(2). e009768–e009768. 19 indexed citations
5.
Xiang, Qian, Alexander Vang, Richard A. F. Dixon, et al.. (2022). A machine learning model to estimate myocardial stiffness from EDPVR. Scientific Reports. 12(1). 5433–5433. 25 indexed citations
6.
7.
Vang, Alexander, Denielli da Silva Gonçalves Bós, Peng Zhang, et al.. (2021). α7 Nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension. JCI Insight. 6(12). 25 indexed citations
8.
Vang, Alexander, et al.. (2021). Acute Functional Adaptation of the Right Ventricle in ARDS. A3696–A3696. 1 indexed citations
9.
Gong, Jiannan, Abigail L. Peterson, Jennifer F. Carr, et al.. (2020). Endothelial to mesenchymal transition during neonatal hyperoxia‐induced pulmonary hypertension. The Journal of Pathology. 252(4). 411–422. 28 indexed citations
10.
McCullough, Danielle J., et al.. (2020). Endurance exercise training in pulmonary hypertension increases skeletal muscle electron transport chain supercomplex assembly. Pulmonary Circulation. 10(2). 1–11. 9 indexed citations
11.
O‐Uchi, Jin, Alexander Vang, Michael W. Cypress, et al.. (2020). Role of Mitochondrial Expression of the Calcium-Activated Chloride Channel Anoctamin-1 in Pulmonary Artery Endothelial Cells. Biophysical Journal. 118(3). 448a–448a. 1 indexed citations
12.
Clements, Richard, et al.. (2019). Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan. Circulation Heart Failure. 12(11). e005819–e005819. 59 indexed citations
13.
White, Alexis, Alexander Vang, Zhengke Wang, et al.. (2019). Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa– induced acute lung injury and NLRP3 inflammasome activation. The FASEB Journal. 34(1). 1516–1531. 20 indexed citations
14.
Harrington, Elizabeth O., et al.. (2017). Activation of the sweet taste receptor, T1R3, by the artificial sweetener sucralose regulates the pulmonary endothelium. American Journal of Physiology-Lung Cellular and Molecular Physiology. 314(1). L165–L176. 32 indexed citations
15.
Allawzi, Ayed, Alexander Vang, Richard Clements, et al.. (2017). Activation of Anoctamin-1 Limits Pulmonary Endothelial Cell Proliferation via p38–Mitogen-activated Protein Kinase–Dependent Apoptosis. American Journal of Respiratory Cell and Molecular Biology. 58(5). 658–667. 45 indexed citations
16.
Chichger, Havovi, Alexander Vang, Kelly A. O’Connell, et al.. (2015). PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 308(8). L827–L836. 21 indexed citations
17.
Sakhatskyy, Pavlo, Julie Newton, Chun Geun Lee, et al.. (2014). Cigarette smoke-induced lung endothelial apoptosis and emphysema are associated with impairment of FAK and eIF2α. Microvascular Research. 94. 80–89. 32 indexed citations
18.
McCullough, Danielle J., Alexander Vang, & Gaurav Choudhary. (2014). NS1619-Induced Vasodilation is Enhanced and Differentially Mediated in Chronically Hypoxic Lungs. Lung. 192(5). 811–817. 7 indexed citations
19.
Casserly, Brian, Alexander Vang, Elizabeth O. Harrington, et al.. (2011). C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade. Life Sciences. 89(13-14). 460–466. 8 indexed citations
20.
Vang, Alexander, et al.. (2010). Activation of endothelial BKCa channels causes pulmonary vasodilation. Vascular Pharmacology. 53(3-4). 122–129. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Nao Breakdown of academic impact, for papers by Christian Schach Breakdown of academic impact, for papers by Sara A. Murphy Breakdown of academic impact, for papers by Arthur Leloup Breakdown of academic impact, for papers by Han Feng Breakdown of academic impact, for papers by Shenglan Guo Breakdown of academic impact, for papers by H. J. L. Speirs Breakdown of academic impact, for papers by Kojiro Ichikawa Breakdown of academic impact, for papers by Péter Ferdinandy Breakdown of academic impact, for papers by Nicholas P. Meermeier
Rankless by CCL
2026